New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States
Go back to New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States| (NASDAQ: DFTX) | Delayed: 36.67 +12.19 (49.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.48 | 52 Week High | $ | |||
| Open | $38.58 | 52 Week Low | $ | |||
| Day High | $39.16 | P/E | N/A | |||
| Day Low | $35.13 | EPS | $ | |||
| Volume | 20,132,668 | |||||
